Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to -$100000.0.

  • CG Oncology's Other Non Operating Income fell 490000.0% to -$100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$93000.0, marking a year-over-year decrease of 122857.14%. This contributed to the annual value of $3000.0 for FY2024, which is 10483.87% up from last year.
  • Latest data reveals that CG Oncology reported Other Non Operating Income of -$100000.0 as of Q3 2025, which was down 490000.0% from -$4000.0 recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Other Non Operating Income peaked at $8000.0 during Q1 2023, and registered a low of -$100000.0 during Q3 2025.
  • Over the past 3 years, CG Oncology's median Other Non Operating Income value was -$4000.0 (recorded in 2023), while the average stood at -$14363.6.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 25000.0% in 2024, then plummeted by 490000.0% in 2025.
  • CG Oncology's Other Non Operating Income (Quarter) stood at -$4000.0 in 2023, then skyrocketed by 250.0% to $6000.0 in 2024, then crashed by 1766.67% to -$100000.0 in 2025.
  • Its Other Non Operating Income was -$100000.0 in Q3 2025, compared to -$4000.0 in Q2 2025 and $5000.0 in Q1 2025.